Chapter 3.3 The role of 11β-hydroxysteroid dehydrogenases in the regulation of corticosteroid activity in the brain

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 1, 2005, Pages 313-328

  Seckl, Jonathan R ^a   Yau, Joyce L W ^a   Holmes, Megan C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250204022     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80018-5     Document Type: Chapter

References (94)

1. Agarwal A.K., Monder C., Eckstein B., and White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11dehydrogenase. J. Biol. Chem. 264 (1989) 18939-18943
2. Ajilore O.A., and Sapolsky R.M. In vivo characterization of 11 beta-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint. Neuroendocrinology 69 2 (1999) 138-144
3. Alberts P., Engblom L., Edling N., Forsgren M., Klingstrom G., Larsson C., Ronquist-Nii Y., Ohman B., and Abrahmsen L. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45 (2002) 1528-1532
4. Albiston A.L., Obeyesekere V.R., Smith R.E., and Krozowski Z.S. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endo. 105 2 (1994) R11-R17
5. Amelung D., Huebener H.J., Roka L., and Meyerheim G. Conversion of cortisone to compound F. Journal of Clinical Endocrinology and Metabolism 13 (1953) 1125-1129
6. Barf T., Vallgarda J., Emond R., Haggstrom C., Kurz G., Nygren A., Larwood V., Mosialou E., Axelsson K., Olsson R., Engblom L., Edling N., Ronquist-Nii Y., Ohman B., Alberts P., and Abrahmsen L. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry 45 18 (2002) 3813-3815
7. Benediktsson R., Calder A.A., Edwards C.R.W., and Seckl J.R. Placental 11β-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin. Endocrinol. 46 (1997) 161-166
8. Bohn M.C., and Lauder J.M. The effects of neonatal hydrocortisone on rat cerebellar development: an autoradiographic and light microscopic study. Dev. Neurosci. 1 (1978) 250-266
9. Bohn M.C., and Lauder J.M. Cerebellar granule cell genesis in hydrocortisone-treated rat. Dev. Neurosci. 3 (1980) 81-89
10. Brown R.W., Chapman K.E., Edwards C.R.W., and Seckl J.R. Human placental 11β-hydroxysteroid dehydrogenase: partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinol. 132 (1993) 2614-2621
11. Brown R.W., Diaz R., Robson A.C., Kotelevtsev Y., Mullins J.J., Kaufman M.H., and Seckl J.R. The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinol. 137 (1996) 794-797
12. Bujalska I., Kumar S., and Stewart P.M. Central obesity: "Cushing's disease of the omentum". Lancet 349 (1997) 1210-1213
13. Burton A.F., and Tufnell R.W. 11-dehydrocorticosteroids in tissues of mice. Canadian Journal of Biochemistry 46 (1967) 497-502
14. de Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Frontiers in Neuroendocrinology 12 (1991) 95-164
15. de Kloet E.R., Wallach G., and McEwen B.S. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinol. 96 (1975) 598-609
16. Dean F., and Matthews S. Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res. 846 (1999) 253-259
17. Diaz R., Brown R.W., and Seckl J.R. Ontogeny of mRNAs encoding glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenases in prenatal rat brain development reveal complex control of glucocorticoid action. J. Neurosci. 18 (1998) 2570-2580
18. Duperrex H., Kenouch S., Gaeggeler H.-P., Seckl J.R., Edwards C.R.W., Farman N., and Rossier B.C. Rat liver 11β-hydroxysteroid dehydrogenase cDNA encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology 132 (1993) 612-619
19. Edwards C.R.W., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., and Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet ii (1988) 986-989
20. Funder J.W., Pearce P.T., Smith R., and Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585
21. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Reviews 15 (1994) 391-407
22. Glock G.E., and McLean P. Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in animal tissues. Biochem. J. 61 (1955) 388-390
23. Gomez-Sanchez E.P. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinol. 118 (1986) 819-823
24. Gomez-Sanchez E.P., Fort C.M., and Thwaites D. Icv infusion of corticosterone antagonises icv-aldosterone hypertension. Am. J. Physiol. (1990) E649-E653
25. Gomez-Sanchez E.P., and Gomez-Sanchez C.E. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am. J. Physiol. 263 (1992) E1125-E1130
26. Grosser B.I. 11β-hydroxysteroid metabolism by mouse brain and glioma 261. J. Neurochem. 13 (1966) 475-478
27. Grosser B.I., and Axelrod L.R. Conversion of cortisol to cortisol acetate, cortisone acetate and cortisone by the developing primate brain. Steroids 11 (1968) 827-836
28. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., and Holmes M.C. 11β-hydroxysteroid dehydrogenase type 1 null mice have altered hypothalamic-pituitary-adrenal axis activity: a novel control of glucocorticoid feedback. Endocrinology 142 (2001) 114-120
29. Hundertmark S., Buhler H., Ragosch V., Dinkelborg L., Arabin B., and Weitzel H.K. Correlation of surfactant phosphatidylcholine synthesis and 11beta-hydroxysteroid dehydrogenase in the fetal lung. Endocrinology 136 (1995) 2573-2578
30. Hundertmark S., Dill A., Buhler H., Stevens P., Looman K., Ragosch V., Seckl J.R., and Lipka C. 11 beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation. Hormone and Metabolic Research 34 10 (2002) 537-544
31. Hundertmark S., Dill A., Ebert A., Zimmermann B., Kotelevtsev Y.V., Mullins J.J., and Seckl J.R. Foetal lung maturation in 11 beta-hydroxysteroid dehydrogenase type 1 knockout mice. Hormone and Metabolic Research 34 10 (2002) 545-549
32. Jamieson P.M., Chapman K.E., Edwards C.R.W., and Seckl J.R. 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultured rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
33. Jamieson P.M., Chapman K.E., and Seckl J.R. Tissue- and temporal-specific regulation of 11β-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo. J. Steroid Biochem. Molec. Biol. 68 (1999) 245-250
34. Jamieson P.M., Chapman K.E., Walker B.R., and Seckl J.R. 11β-hydroxysteroid dehydrogenase type 1 is a predominant 11β-reductase in the intact perfused rat liver. J. Endocrinol. 165 (2000) 685-692
35. Jamieson P., Fuchs E., and Seckl J. Chronic psychosocial stress attenuates 11β-hydroxysteroid dehydrogenase activity in the hippocampus and liver in the tree-shrew. Stress 2 (1997) 123-132
36. Jellinck P.H., Monder C., McEwen B.S., and Sakai R.R. Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J. Steroid Biochem. Molec. Biol. 46 (1993) 209-213
37. Johnstone H.A., Wigger A., Douglas A.J., Neumann I.D., Landgraf R., Seckl J.R., and Russell J.A. Attenuation of hypothalamic-pituitary-adrenal axis stress responses in late pregnancy: changes in feedforward and feedback mechanisms. Journal of Neuroendocrinology 12 8 (2000) 811-822
38. Kotelevtsev Y., Brown R.W., Fleming S., Kenyon C.J., Edwards C.R.W., Seckl J.R., and Mullins J.J. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 103 (1999) 683-689
39. Kotelevtsev Y., Holmes M.C., Burchell A., Houston P.M., Schmoll D., Jamieson P.M., Best R., Brown R., Edwards C.R.W., et al. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress. Proc. Natl. Acad. Sci. USA 94 (1997) 14924-14929
40. Lakshmi V., and Monder C. Purification and characterisation of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinol. 123 (1988) 2390-2398
41. Lakshmi V., Sakai R.R., McEwen B.S., and Monder C. Regional distribution of 11β-hydroxysteroid dehydrogenase in rat brain. Endocrinol. 128 (1991) 1741-1748
42. Landfield P.W., Waymire J., and Lynch G. Hippocampal aging and adrenocorticoids: a quantitative correlation. Science 202 (1978) 1098-1102
43. Levitt N., Lindsay R.S., Holmes M.C., and Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64 (1996) 412-418
44. Lopez-Bernal A., Flint A.P.F., Anderson A.B.M., and Turnbull A.C. 11β-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J. Steroid Biochem. 13 (1980) 1081-1087
45. Low S.C., Assaad S.N., Rajan V., Chapman K.E., Edwards C.R.W., and Seckl J.R. Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. Journal of Endocrinology 139 (1993) 27-35
46. Low S.C., Chapman K.E., Edwards C.R.W., and Seckl J.R. Liver-type 11β-hydroxysteroid dehydrogenase cDNA encodes reductase not dehydrogenase activity in intact mammalian COS-7 cells. Journal of Molecular Endocrinology 13 (1994) 167-174
47. Low S.C., Moisan M.-P., Edwards C.R.W., and Seckl J.R. Glucocorticoids and chronic stress up-regulate 11β-hydroxysteroid dehydrogenase activity and gene expression in the hippocampus. J. Neuroendocrinol. 6 (1994) 285-290
48. Maccari S., Piazza P.V., Kabbaj M., Barbazanges A., Simon H., and Le Moal M. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. Journal of Neuroscience 15 (1995) 110-116
49. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the Metabolic Syndrome. Science 294 (2001) 2166-2170
50. Matthews S.G. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol. Metab. 130 (2002) 373-380
51. Mattsson C., Lai M., Noble J., McKinney E., Yau J.L.W., Seckl J.R., and Walker B.R. Reduced mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 expression in hippocampus of Zucker fat rats; mechanisms for altered feedback control of the hypothalamic-pituitary-adrenal axis in obesity. Endocrinology 144 (2003) 2997-3003
52. McEwen B.S. Stress and hippocampal plasticity. Annual Review of Neuroscience 22 (1999) 105-122
53. McEwen B.S., de Kloet E.R., and Rostene W. Adrenal steroid receptors and action in the nervous system. Physiol. Rev. 66 (1986) 1121-1188
54. McEwen B.S., Lambdin L.T., Rainbow T.C., and De Nicola A.F. Aldosterone effects on salt appetite in adrenalectomised rats. Neuroendocrinol. 43 (1986) 38-43
55. Meaney M.J., Aitken D.H., van Berkel C., Bhatnagar S., and Sapolsky R.M. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239 (1988) 766-768
56. Meaney M.J., O'Donnell D., Rowe W., Tannenbaum B., Steverman A., Walker M., Nair N.P.V., and Lupien S. Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Experimental Gerontology 30 (1995) 229-251
57. Meyer J.S. Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp. Neurol. 82 (1983) 432-446
58. Miyabo S., Kishida S., and Hisada T. Metabolism and conjugation of cortisol by various dog tissues in vitro. Journal of Steroid Biochemistry 4 (1973) 567-576
59. Moisan M.-P., Edwards C.R.W., and Seckl J.R. Ontogeny of 11β-hydroxysteroid dehydrogenase in rat brain. Neuroendocrinol. 52 Suppl. 1 (1990) 137
60. Moisan M.-P., Seckl J.R., Brett L.P., Monder C., Agarwal A.K., White P.C., and Edwards C.R.W. 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid expression, bioactivity and immunoreactivity in rat cerebellum. J. Neuroendocrinol. 2 (1990) 853-858
61. Moisan M.-P., Seckl J.R., and Edwards C.R.W. 11β-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus and cortex. Endocrinology 127 (1990) 1450-1455
62. Monder C., and Lakshmi V. Corticosteroid 11β-dehydrogenase of rat tissues: immunological studies. Endocrinology 126 (1990) 2435-2443
63. Morton N.M., Holmes M.C., Fievet C., Staels B., Mullins J.J., and Seckl J.R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. 276 (2001) 41293-41300
64. Mune T., Rogerson F.M., Nikkilä H., Agarwal A.K., and White P.C. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genetics 10 (1995) 394-399
65. Napolitano A., Voice M., Edwards C.R.W., Seckl J.R., and Chapman K.E. 11β-hydroxysteroid dehydrogenase type 1 in adipocytes: expression is differentiation-dependent and hormonally-regulated. J. Steroid Biochem. Molec. Biol. 64 (1998) 251-260
66. Nitabach M.N., Schulkin J., and Epstein A. The medial amygdala is part of a mineralocorticoid-sensitive circuit controlling NaCl ingestion in the rat. Behav. Brain Res. 35 (1989) 159-161
67. A antagonist in the guinea pig isolated ileum. J. Pharm. Pharmacol. 42 (1990) 662-664
68. Ozols J. Lumenal orientation and post-translational modification of the liver microsomal 11β-hydroxysteroid dehydrogenase. J. Biol. Chem. 270 (1995) 2305-2312
69. Peterson N.A., Chaikoff I.L., and Jones C. The in vitro conversion of cortisol to cortisone by subcellular brain fractions of young and adult rats. J. Neurochem. 12 (1965) 273-278
70. Rajan V., Edwards C.R.W., and Seckl J.R. 11β-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J. Neuroscience 16 (1996) 65-70
71. Robson A.C., Leckie C., Seckl J.R., and Holmes M.C. Expression of 11β-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Molec. Brain Res. 61 (1998) 1-10
72. Roland B.L., Li K.X.Z., and Funder J.W. Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinol. 136 (1995) 4697-4700
73. # 7773. Sakai R.R., Lakshmi V., Monder C., Funder J.W., Krozowski Z., and McEwen B.S. Colocalization of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptor in rat brain. Soc. Neurosci. Abstr (1990)
74. Sakai R.R., Lakshmi V., Monder C., and McEwen B.S. Immunocytochemical localisation of 11beta-hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat. J. Neuroendocrinol. 4 (1992) 101-106
75. Seckl J.R. 11β-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?. Front. Neuroendocrinol. 18 (1997) 49-99
76. Seckl J.R. Physiologic programming of the fetus. Clinics Perinatol. 25 (1998) 939-964
77. Seckl J.R., and Walker B.R. 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
78. Seckl J.R., Dow R.C., Low S.C., Edwards C.R.W., and Fink G. The 11β-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides. J. Endocrinol. 136 (1993) 471-477
79. 14 C by rat brain homogenates. Metab. Clin. Exp. 14 (1965) 1122-1127
80. Stewart P.M., and Krozowski Z.S. 11 beta-hydroxysteroid dehydrogenase. Vitamins and Hormones 57 (1999) 249-324
81. Stewart P.M., Valentino R., Wallace A.M., Burt D., Shackleton C.H.L., and Edwards C.R.W. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii (1987) 821-824
82. Stewart P.M., Wallace A.M., Atherden S.M., Shearing C.H., and Edwards C.R.W. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 78 (1990) 49-54
83. Thieringer R., Le Grand C., Carbin L., Cai T.-Q., Wong B., Wright S.D., and Hermanowski-Vosatka A. Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J. Immunol. 167 (2001) 30-35
84. Tye L.M., and Burton A.F. Variation in the pattern of metabolism of corticosteroids in fetal mouse tissues. Life Sci. 26 (1980) 35-39
85. Venihaki M.A., Carrigan P., Dikkes P., and Majzoub A. Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency. Proc. Natl. Acad. Sci. USA 97 (2000) 7336-7341
86. Vreugdenhil E., and deKloet E.R. Corticosteroid hormones and neuronal vulnerability: towards identification of candidate vulnerability genes. Progress in Brain Research 117 (1998) 9-22
87. Walker B.R., Campbell J.C., Fraser R., Stewart P.M., and Edwards C.R.W. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clinical Endocrinology 37 (1992) 483-492
88. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 65 (2001) 427-451
89. Welberg L.A.M., and Seckl J.R. Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13 (2001) 113-128
90. Welberg L.A.M., Seckl J.R., and Holmes M.C. Inhibition of 11β-hydroxysteroid dehydrogenase, the feto-placental barrier to maternal glucocorticoids, permanently programs amygdala glucocorticoid receptor mRNA expression and anxiety-like behavior in the offspring. Europ. J. Neurosci. 12 (2000) 1047-1054
91. Welberg L.A.M., Seckl J.R., and Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 104 (2001) 71-79
92. Yau J.L.W., and Seckl J.R. 11 beta-hydroxysteroid dehydrogenase type I in the brain; thickening the glucocorticoid soup. Molecular Psychiatry 6 6 (2001) 611-614
93. Yau J.L.W., Noble J., Kenyon C.J., Hibberd C., Kotelevtsev Y., Mullins J.J., and Seckl J.R. Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. USA 98 (2001) 4716-4721
94. Yongue B.G., and Roy E.J. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res. 436 (1987) 49-61